Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P39060 (
endostatin
)
2,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Research studies suggest that tumor-related angiogenesis contributes to the phenotype of malignant gliomas. We assessed the effect of local delivery of the angiogenesis inhibitor
endostatin
on human glioma cell line (U-87MG) xenografts. Baby hamster kidney (BHK) cells were stably transfected with a human
endostatin
(hES) expression vector and were encapsulated in alginate-poly L-lysine (PLL) microcapsules for long-term delivery of hES. The release of biologically active
endostatin
was confirmed using assays of bovine capillary endothelial (BCE) proliferation and of tube formation. Human
endostatin
released from the microcapsules brought about a 67. 2% inhibition of BCE proliferation. Furthermore, secreted hES was able to inhibit tube formation in KDR/
PAE
cells (porcine aortic endothelial cells stably transfected with KDR, a tyrosine kinase) treated with conditioned U-87MG medium. A single local injection of encapsulated
endostatin
-secreting cells in a nude mouse model resulted in a 72.3% reduction in subcutaneous U87 xenografts' weight 21 days post treatment. This inhibition was achieved by only 150.8 ng/ml human
endostatin
secreted from 2 x 10(5) encapsulated cells. Encapsulated
endostatin
-secreting cells are effective for the treatment of human glioblastoma xenografts. Continuous local delivery of
endostatin
may offer an effective therapeutic approach to the treatment of a variety of tumor types.
...
PMID:Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. 1113 44
Endostatin, a carboxy-terminal fragment of
collagen XVIII
, has been shown to act as an anti-angiogenic agent that specifically inhibits proliferation of endothelial cells and growth of various primary tumors. Here, we describe the expression by Chinese hamster ovary (CHO) cells of murine
endostatin
and of a tagged-fusion protein, (his)6-met-
endostatin
. A dicistronic mRNA expression vector was utilized in which
endostatin
cDNA was inserted upstream of the amplifiable marker gene, dihydrofolate reductase (DHFR). After transfection of the expression vectors, stepwise increments in methotrexate levels in the culture medium were applied, promoting gene amplification and increasing expression levels of the proteins of interest. The expression level of secreted native
endostatin
was about 78 microg/mL while the one for secreted (his)6-met-
endostatin
was about 114 microg/mL, for the best expressing clones. Characterization of physico-chemical and immunological activities of the proteins was performed using SDS-PAGE and Western blotting. The biological activities of recombinant endostatins were tested with a cow pulmonary artery endothelial (C-PAE) cell proliferation assay. Both recombinant
endostatin
and (his)6-met-
endostatin
inhibited, in a dose-dependent fashion, growth of C-
PAE
cells stimulated by basic fibroblast growth factor (bFGF).
...
PMID:High-level synthesis of recombinant murine endostatin in Chinese hamster ovary cells. 1503 60